Gastro Health

Gastro Health is a healthcare provider specializing in gastroenterology, offering comprehensive diagnostic and treatment options for a wide range of digestive health issues.

CCI Score

1.53

April 16

Latest Event

Gastro Health Partners in IBD Data Collaboration

Gastro Health has joined forces with Lynx.MD and Prometheus Laboratories in a partnership that leverages their extensive real-world data repository to advance inflammatory bowel disease research. The collaboration utilizes secure, de-identified clinical data to assess the effectiveness of therapeutic drug monitoring, potentially improving patient outcomes.

Take Action

So what can you do? Support Gastro Health by shopping, spreading the word, or offering your support.

Shop Alternatives SEE ALL: Northwestern Medicine

NHS

Cleveland Clinic
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

OBJECTOR

Gastro Health is currently rated as an Objector.

0 to +9 CCI Score

These companies deliberately avoid direct involvement with authoritarian practices. While they do not actively challenge oppressive regimes, they maintain a neutral stance to ensure they are not complicit in supporting such systems.

Latest Events

OCT

01

2023

Gastro Health Partners in IBD Data Collaboration
27.83

Gastro Health has joined forces with Lynx.MD and Prometheus Laboratories in a partnership that leverages their extensive real-world data repository to advance inflammatory bowel disease research. The collaboration utilizes secure, de-identified clinical data to assess the effectiveness of therapeutic drug monitoring, potentially improving patient outcomes.
+30

Business Practices and Ethical Responsibility

April 3

Gastro Health's role in sharing its large repository of de-identified clinical data for research demonstrates ethical business practices. By promoting transparency and supporting research that can improve treatment options for IBD patients, the company is contributing positively to community health and advancing progressive, patient-centered care.

Lynx.MD Partners with Prometheus Laboratories and Gastro Health to Leverage Medical Data Intelligence Platform for Inflammatory Bowel Disease Research
+35

Technology and Services Impact

April 3

The partnership leverages advanced data intelligence technology through the Lynx.MD platform, ensuring secure handling and compliance with privacy regulations (HIPAA and GDPR). This responsible use of technology to generate insights for improved therapeutic approaches underscores a commitment to progressive and patient-focused healthcare innovation.

Lynx.MD Partners with Prometheus Laboratories and Gastro Health to Leverage Medical Data Intelligence Platform for Inflammatory Bowel Disease Research
AUG

06

2021

Failure to Inform Staff of Right to Paid Medical Leave
-41.43

A lawsuit alleges that Gastro Health failed to inform employees about their right to paid medical leave under the FMLA and retaliated against those who sought to exercise this right, raising concerns over the company's labor practices.
-60

Labor Relations and Human Rights Practices

April 3

The allegations indicate that Gastro Health neglected to inform employees of their legally entitled paid medical leave under the FMLA and is accused of retaliatory terminations. Such actions reflect a disregard for worker rights and proper labor relations, thereby contributing negatively to the company's record in ethical labor practices.

Gastro Health Failed to Inform Staff of Right to Paid Medical Leave, Suit Claims
AUG

07

2018

Acquisition of Central Florida Gastroenterology
18.19

Gastro Health expanded its operations in Central Florida with the acquisition of Internal Medicine Specialists, Inc. DBA Central Florida Gastroenterology. The deal added eight physicians, six advanced practitioners, nine new office locations, and two endoscopy centers, aiming to enhance patient care and service access in the region.
+40

Business Practices and Ethical Responsibility

April 3

The acquisition demonstrates Gastro Health’s commitment to expanding quality healthcare services. By integrating a large, established gastroenterology group, the company is enhancing patient access and care, reflecting positive ethical business practices that benefit community health.

Gastro Health Acquired Central Florida Gastroenterology
+30

Economic and Structural Influence

April 3

This strategic acquisition enhances Gastro Health’s economic and structural influence in the Central Florida region. By strengthening its infrastructure and market presence, the move is likely to improve operational efficiencies and service delivery, which supports community wellbeing.

Gastro Health Acquired Central Florida Gastroenterology